BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL

被引：0
|
作者：
Anand, Inderjit S. [1 ]
Hetzel, Scott J. [1 ]
Miller, Alan B. [1 ]
Carson, Peter E. [1 ]
Gaasch, William H. [1 ]
Haass, Markus [1 ]
Little, William C. [1 ]
Lopez-Sendon, Jose [1 ]
Massie, Barry M. [1 ]
McMurray, John J. [1 ]
Ptaszynska, Agata [1 ]
Teerlink, John R. [1 ]
White, Michel [1 ]
Zile, Michael R. [1 ]
机构：
[1] VA Med Ctr, Minneapolis, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1236-78
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction Results of the I-PRESERVE Collagen Substudy
    Krum, Henry
    Elsik, Maros
    Schneider, Hans G.
    Ptaszynska, Agata
    Black, Marion
    Carson, Peter E.
    Komajda, Michel
    Massie, Barry M.
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Anand, Inder S.
    CIRCULATION-HEART FAILURE, 2011, 4 (05) : 561 - 568
  • [32] Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction findings from the irbesartan in heart failure with preserved systolic function trial (I-PRESERVE)
    Zile, Michael R.
    Komajda, Michel
    McKelvie, Robert
    McMurray, John
    Donovan, Mark
    Ptaszynska, Agata
    Carson, Peter
    Massie, Barry M.
    CIRCULATION, 2007, 116 (16) : 706 - 707
  • [33] Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve)
    McMurray, John J.
    Komajda, Michel
    McKelvie, Robert
    Zile, Michael
    Ptaszynska, Agata
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION, 2007, 116 (16) : 552 - 552
  • [34] Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
    Arundel, Cherinne
    Lam, Phillip H.
    Gill, Gauravpal S.
    Patel, Samir
    Panjrath, Gurusher
    Faselis, Charles
    White, Michel
    Morgan, Charity J.
    Allman, Richard M.
    Aronow, Wilbert S.
    Singh, Steven N.
    Fonarow, Gregg C.
    Ahmed, Ali
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (24) : 3054 - 3063
  • [35] Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
    Huang, Rihua
    Lin, Yifen
    Liu, Menghui
    Xiong, Zhenyu
    Zhang, Shaozhao
    Zhong, Xiangbin
    Ye, Xiaomin
    Huang, Yiquan
    Zhuang, Xiaodong
    Liao, Xinxue
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (07):
  • [36] Association between trajectory of systolic blood pressure and outcomes in heart failure patients with preserved ejection fraction (HFpEF)
    Liu, Xiao
    Pan, Hong
    Jiang, Yuan
    Wang, Yue
    Abudukeremu, Ayiguli
    Cao, Zhengyu
    Wu, Maoxiong
    He, Wanbing
    Zhang, Minghai
    Yan, Zhiwei
    Gao, Qingyuan
    Zhu, Wengen
    Zhang, Haifeng
    Zhang, Yuling
    Chen, Yangxin
    Wang, Jingfeng
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 131 : 89 - 97
  • [37] Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)
    Boehm, Michael
    Perez, Ana-Cristina
    Jhund, Pardeep S.
    Reil, Jan C.
    Komajda, Michel
    Zile, Michael R.
    McKelvie, Robert S.
    Anand, Inder S.
    Massie, Barry M.
    Carson, Peter E.
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (07) : 778 - 787
  • [38] Health related quality of life in the Irbesartan in heart failure with preserved systolic function trial (I-PRESERVE)
    Mcmurray, J. J. V.
    Rector, T. S.
    Carson, P. E.
    Beusterien, K.
    Komajda, M.
    Mckelvie, R.
    Zile, M.
    Ptaszynska, A.
    Staiger, C.
    Massie, B. M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 156 - 156
  • [39] SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian
    Bohm, Michael
    Anker, Stefan D.
    Vaduganathan, Muthiah
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 680 - 680
  • [40] DIASTOLIC BLOOD PRESSURE AND ADVERSE OUTCOMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Sandesara, Pratik
    Dhindsa, Devinder
    O'Neal, Wesley
    Khambhati, Jay
    Sperling, Laurence
    Lee, Suegene
    CLINICAL CARDIOLOGY, 2017, 40 : 10 - 10
12345